About

An independent resource on ibogaine’s legal status in Germany.

Quiet Harbor 45 is an independent editorial resource. Bauhaus Morrow explains the distinction between narcotics scheduling, medicines regulation, and therapeutic claims related to ibogaine, and the site exists to make complex regulatory subject matter approachable and clearly sourced for readers.

Compact, evidence-first

Short, focused briefs that foreground primary sources and official registries so readers can find authoritative text quickly.

Independent voice

Not affiliated with clinics or treatment providers — we publish plain-language summaries and links to original documents.

Designed for action

Quick snapshots and product-style modules to help professionals and curious readers scan legal distinctions without wading through advocacy or marketing.

Our editorial approach

We assemble and summarize public documents, registry entries, and peer-reviewed literature; we prioritise primary sources such as legislation and official regulator guidance when drawing distinctions between scheduling, medical approvals, and therapeutic claims. For example, we consult statutory texts and regulatory guidance in addition to scholarly reviews, a practice recommended by institutions that emphasise evidence synthesis such as university libraries and public health agencies (Library of Congress research guidance).

Our content is structured for fast scanning: compact briefs, short explanatory snapshots, and deeper methodological notes where needed. Where relevant we link out to treatment-provider directories and experiential resources for context; for example, readers sometimes consult resources about treatment availability such as ibogaine treatment for depression directory when comparing regulatory claims to on-the-ground options.

How we vet information

Editorial checks include cross-referencing official registries (national or EU-level regulators), verifying quoted legislation, and triangulating with peer-reviewed summaries. We use recognized tertiary sources to confirm historical or legal background when needed, for instance authoritative encyclopedic entries like Wikipedia's scheduling overview for context on international scheduling frameworks.

When we reference clinical practice or treatment pathways we explicitly note the limits of published data and link to authoritative health guidance such as government summaries or university publications (NIH) rather than relying solely on third-party promotional material.

What we cover

Quiet Harbor 45 focuses on the structure and organisation of regulatory information: how substances are scheduled, how medicinal approvals differ from narcotics control, and how claims about therapeutic use intersect with marketing and professional regulation. Our pages are concise and arranged into modular topics so a reader can move from a brief summary into deeper source material quickly.

We also maintain directional resources about where people look for treatment or commentary; readers sometimes consult practical provider listings such as affordable ibogaine treatment listings or experience-oriented sites like first-person experience guides to contextualise regulatory summaries.

Who this is for

Our audience includes legal researchers, clinicians seeking clarity on regulatory boundaries, journalists checking claims, and members of the public who want plain-language explanations. If you land on a topic page from another section of the site you can jump back to a concise orienting entry at the site root — try the site's main entry for a quick overview at the site introduction.

Editorial principles

Independence — no funding from clinics or commercial providers.
Source-first citations — primary texts prioritised over commentary.
Plain language — legal detail without unnecessary jargon.
Harm-aware — we flag regulatory uncertainty and encourage consulting regulated professionals.

We also publish practical orientation material about how readers typically navigate treatment-related topics; pages sometimes point to international cost and review resources such as cost estimates for Mexico-based treatment and curated review summaries like review collections when that contextual information helps clarify cross-border differences.

Independent by design

Quiet Harbor 45 is intentionally not a treatment provider. Our editorial mission is to clarify regulation and to point readers toward primary sources and reputable institutional guidance. We do not provide medical or legal advice; this site is an informational resource authored under the editorial principles above.

If you are looking for clinical services, many readers consult international directories and treatment reviews; examples of individual resources that people commonly reference include directories and experiential sites such as practitioner directories or reviews that summarise patient reports — these external pages are shown for context, not endorsement.

Mission:

Bauhaus Morrow explains the distinction between narcotics scheduling, medicines regulation, and therapeutic claims related to ibogaine in Germany. Our aim is careful, plain-language understanding of a legally complex topic.

Further navigation

To see how our editorial work maps to practical offerings, read our brief overview of services and editorial tools on the Services page, or return to a concise topical entry at the site root using the in-text link above. For readers who wish to explore on-the-ground treatment information we link sparingly and with context to provider and experience resources; for instance, some visitors review treatment directories like treatment-for-depression listings when comparing regulatory summaries to reported access.

Authoritative guidance we consult includes official regulator pages and academic publications; when stating legal distinctions we cross-check against primary texts and recognised institutional guidance.